Table: Hisamitsu -2022/23 parent results
Apr 13 (Reuters)-
Hisamitsu Pharmaceutical Co Inc
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Feb 28, 2023 Feb 28, 2022 Feb 29, 2024 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 92.98 90.59
(+2.6 pct) (+4.5 pct)
Operating 10.85 8.62
(+25.9 pct) (-8.7 pct)
Recurring 14.06 10.61
(+32.5 pct) (+2.3 pct)
Net 10.41 7.17
(+45.3 pct) (-14.1 pct)
EPS 131.21 yen 88.25 yen
EPS Diluted 131.10 yen 88.19 yen
Ann Div 84.50 yen 84.00 yen 85.00 yen
-Q2 Div 42.25 yen 42.00 yen 42.50 yen
-Q4 Div 42.25 yen 42.00 yen 42.50 yen
NOTE - Hisamitsu Pharmaceutical Co Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4530.T
Recent news on Hisamitsu Pharmaceutical Co
See all newsTable: Hisamitsu -2025/26 group results
Table: Hisamitsu -2025/26 parent results
Brief: Hisamitsu Pharmaceutical Co Inc - To Retire Treasury Shares Worth 6.34% Of Outstanding Stock On May 12
Brief: Hisamitsu Pharmaceutical Co Inc - Tender Offer Of Company By Taiyo Kosan Successfully Completed
Japan's Hisamitsu Pharmaceutical plans $2.55 billion MBO